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Effects of Changes in Calmodulin Levels on
Cell Proliferation
Colin D. Rasmusen* and Anthony R. Means*
Calmodulin (CaM) is one of several proteins regulated in a cell cycle-dependent manner. CaM is
synthesized at the Gl/S boundary and has been implicated in the regulation of cell cycle progres-
sion. To elucidate the role of calmodulin in cell cycle control, clonal mouse C127 cell lines trans-
formed with one offour different bovine papilloma virus (BPV)-based vectors were studied. These
vectors express a) a chicken CaM gene regulated by its own promoter (CM cells), b) the chicken
CaM gene regulated by the inducible human metallothionein-IIa promoter (MCM cells), c) CaM
antisense RNA using the Zn2+ inducible mouse metallothionein-I (mMT-I) promoter (AS cells), ord)
a rat parvalbumin gene using the chicken CaM promoter (PV cells). C127 cells transformed by
BPV-1 alone (BPV cells) are used as a control in each case. Previous studies showed that a 4-fold
increase in CaM levels in CM cells shortened the cell cycle by reducing the length ofthe GI period.
Expression ofparvalbumin in PV cells has no effect on cell cycle length, suggesting that increased
CAM, and not simply increased Ca2"-binding protein, accelerates proliferation. Zn21-induced
expression of the chicken CaM gene in MCM cells increased the rate of proliferation, while Zn2+-
induced expression of high levels of CaM anti-sense RNA stops proliferation at Zn2+ levels that do
not affect the growth ofBPV cells. In CM cells increased CaM affects cell cycle-dependent level of
mRNAs for tubulin, vimentin, and c-myc relative to the levels in BPV cells. Tubulin mRNA levels
are decreased 2-fold in CM cells due to decreased tubulin mRNA half-life. Vimentin and c-nyc
mRNAs that have been previously shown to respond to mitogenic stimulation are increased in CM
cells. We also observe that c-myc mRNA increases 2- to 3-fold in both CM and BPV cells as they
progress from mitosis to G1. This is the first demonstration of regulation of c-myc mRNA over the
course of the cell cycle in exponentially growing cells. Previous studies have shown that CaM is
required for quiescent cells to reenter the cell cycle. Quiescent CM cells begin DNA synthesis 2.5
hr earlier than do BPV or PV cells after mitogenic stimulation, indicating that CaM levels have a
direct effect on the rate ofGO-S transit. We are currently examining the effect of increased (using
CM cells) or decreased CAM levels (via anti-sense RNA induction) on cell cycle-dependent gene
expression during cell cycle reentry in response to mitogens.
Introduction
Calmodulin, the ubiquitous Ca2"-binding protein,
interacts with a large number of intracellular targets
and mediates many of the Ca2'-dependent functions
in nonmuscle cells (1). Calmodulins have been found
in all eukaryotes from yeast to mammals (2-5) and
show a remarkable conservation of the primary
amino acid sequence. Calmodulin-dependent enzymes
are involved in a vast array of cellular processes
including cyclin nucleotide and glycogen metabolism,
secretion, and cell motility. Calmodulin is also
thought to be involved in the regulation of cell growth
and proliferation. The transformation of cells by
chemical carcinogens or oncogenic viruses is usually
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accompanied by an increase in the cellular concentra-
tion of CaM (6-11). Previous studies with Chinese
hamster ovary (CHO) cells have shown that CaM
antagonists reversibily block cell cycle progression
both in quiescent cells mitogenically stimulated to
reenter the cell cycle and in exponentially growing
cells (12,13). In addition, CaM and its mRNA are both
regulated, although not coordinately, during the cell
cycle in exponentially growing CHO cells (12,14;
Rasmussen and Means, unpublished observations).
In CHO cells CaM levels double abruptly at the
G1/S boundary of the cell cycle, and this increase is
strongly correlated with the entry of cells into S
phase (12,13). Together, these observations provided
convincing but correlative evidence that CaM levels
influenced cell cycle progression, and hence the rate
of proliferation.
The present studies were designed to address
whether or not a direct relationship exists between
CaM levels and cell proliferation. Our approach to
more clearly define the CaM role in regulating cellRASMUSENAND MEANS
proliferation has been to construct a set of bovine
papilloma-virus based (BPV-based) eukaryotic
expression vectors to elevate or decrease intracellular
CaM levels.
Vector Construction and Isolation of
Cell Lines
A series of five expression vectors have been con-
structed and used to stably transform mouse C127
cells (15). Both the vectors and procedures used have
been previously described (16). We selected BPV as an
expression vector since it is maintained as a stable
episome in mouse C127 cells. The result is that the
gene of interest is maintained in a consistent chroma-
tin environment. Further, the lack of random integra-
tion into the host genome precludes the possibility of
altering or disrupting the expression of a gene
required for normal cell function. The five vectors
used are listed below. The name in brackets is the
designation given to isolated cell lines transformed by
each expression vector.
(A) pdBPV-1 (BPV Cells)
The vector pdBPV-1 contains the entire BPV-1 gen-
ome and sequences from the pBR322 derivative pML2
to allow propagation in E. coli (15). This vector serves
as a control for the effect of transformation on C127
cells by BPV alone.
(B) BPV-CM (CM Cells)
The vector BPV-CM contains the 69% transforming
region of BPV-1 and a chicken CaM whose transcrip-
tion is regulated by the chicken CaM promoter. Cells
transformed by BPV-CM have CaM mRNA levels 20
to 50 times normal and CaM levels which are consti-
tutively 5-fold higher than pdBPV-1 transformed con-
trols 17).
(C) BPV-MCM (MCM Cells)
The vector BPV-MCM contains the 69% transform-
ing region of BPV, and the chicken CaM gene present
in BPV-CM but in this instance transcription of the
CaM gene is regulated by the inducible human metal-
lothionein-IIa promoter (hMT-IIa), obtained from M.
Karin (18). The hMT-IIa promoter was selected since
it is regulated by divalent cations (e.g., Zn2+) and
glucocorticoids, thus allowing CaM mRNA and pro-
tein levels to be elevated in an inducible manner.
(D) BPV-CaMAS (AS Cells)
The vector BPV-CaMAS contains the 69% trans-
forming region of BPV-1 and a 1.0 kb portion of the
chicken CaM cDNA (4), including the entire coding
sequence, placed in inverted orientation 3' to the
inducible mouse metallothionein-I (mMT-1) promoter
(19). This vector allows the inducible production of
CaM anti-sense RNA in a stable cell line.
(E) BPV-CaMPV (PV Cells)
In assessing the role of CaM in cell function, one
must distinguish between effects due to CaM activity
and those which may be attributable to increased
levels of the Ca2'-binding protein within the cell. In
order to distinguish between these two alternatives,
we have produced a vector which expresses a rat
parvalbumin cDNA (20) regulated by the chicken
CaM promoter. Parvalbumin binds Ca2' with high
affinity, but cannot substitute for CaM relative to any
of the known activities of the latter protein (21). Fur-
ther, the use of the CaM promoter to drive the tran-
scription of the parvalbumin gene allows
determination of whether or not the cell cycle-depen-
dent expression of CaM mRNA is due to transcrip-
tional or post-transcriptional mechanisms.
Results and Discussion
Clonal cell lines transformed with each of the five
vectors described above have been isolated and char-
acterized in detail. Since we were interested in ascer-
taining whether or not CaM played a direct role in
cell proliferation, the effects of increased CaM on
growth rate were studied. The growth characteristics
of BPV, CM, and PV cells are summarized in Table 1.
The results indicate that the increased levels of CaM
present in CM cells results in a shortened cell cycle
relative to the BPV cell line. Detailed analysis has
shown this attributable solely to a reduction in the
length of the G1 period (17). In contrast, expression of
parvalbumin in PV cells did not result in a shortened
cell cycle. Thus, the effects of increased CaM on cell
growth are specific for CaM and are not a result of
simply increasing the intracellular Ca2"-binding pro-
tein concentration.
In contrast, both PV and CM cells grow to a higher
saturation density than do control cells. This suggests
that transition from cycling to quiescence may
depend on the total intracellular Ca2"-binding capac-
ity and is not specifically related to an increase in
CaM levels.
Most of the conclusions regarding the involvement
of CaM in regulating cell proliferation has been the
result of previous studies that examined the effects of
Table 1. Growth characteristics of transformed cell lines.
CaM levels, Cell cycle length, Sat. density,
Cell line ng/106 cells hr cells/dish
BPV-1 410 ng 14.7 hr 2.3 x 106
pVy7a 419 ng 15.5 hr 4.0 x 106
CM-1 1810 ng 12.7 hr 4.2 x 106
aPV-7 cells express PV at a concentration of 700 ng/106 cells.
There is no detectable parvalbumin mRNA or protein in BPV-1
or CM-1 cells.
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anti-CaM drugs [e.g., naphthalenesulfonamides (22)]
on cell proliferation. While these drugs do inhibit
CaM activity in vitro, their specificity in cells is not
absolute, and these agents can also interact with
alternative intracellular targets such as protein kin-
ase C.
A more specific method of lowering the effective
concentration of CaM would be to prevent its synthe-
sis by the production of a CaM anti-sense RNA com-
plementary to the endogenous CaM mRNA. We have
constructed a BPV-based vector (BPV-CaMAS) that
contains a chicken CaM cDNA (including 1 kb of
sequence beginning with the initiator ATG codon)
placed in an inverted orientation 3' to the mouse
metallothionein-I promoter. This promoter responds
acutely to levels of ZnSO4 that are not inhibitory to
normal cell growth (23).
We have isolated and characterized two indepen-
dent cell lines (AS-8 and AS-12) which stably main-
tain the BPV-CaMAS vector and produce high levels
of CaM anti-sense RNA when cultured in the presence
of 80 FM ZnSO4. Anti-sense RNA levels increase for 6
to 8 hr following the addition ofZn2+ and then decline.
This transient effect is characteristic of mMT-I pro-
moter response to induction with Zn2+ (23). Concomi-
tant with the appearance of CaM anti-sense RNA,
there is a rapid decrease in intracellular CaM levels
from 420 ng to 300 ng/106 cells, a value nearly that
which is present in G1 (250 ng/106 cells). Between 8 to
12 hr after the addition of Zn2+, CaM levels return to
normal as anti-sense RNA levels decline.
The effect of reduced CaM levels on the prolifera-
tion of exponentially growing AS cells is striking.
From 2 hr until 8 hr after the addition of Zn2+ to the
culture medium, there is no increase in the number of
cells expressing CaM anti-sense RNA. In contrast, an
addition of the same concentration of Zn2+ to BPV-1
control cells has no effect on proliferation. After 8 hr,
the cell number begins to increase again, and prolifer-
ation resumes at a rate similar to that ofcontrol cells.
In contrast to AS cells, cells transformed with the
BPV-MCM vector transiently increase CaM levels 2-
fold in response to 80 jM ZnSO4. The transient eleva-
tion of CaM levels results in an increased rate of
growth of MCM cells from 2 to 12 hr following an
addition of inducer. Thus, a transient increase of CaM
levels in MCM cells affects cell proliferation in a man-
ner analogous but opposite of that observed when
CaM levels are transiently decreased in AS cells. The
observation that cell proliferation is affected immedi-
ately on transient alteration of CaM levels suggests
two possibilities. First, changes in CaM levels may
exert a general effect on cell cycle progression in all
cells, regardless of cell cycle position. Alternatively,
CaM may act through regulation of a specific event
late in the cell cycle that is required for completion of
the cell cycle. We are currently examining the cell
cycle kinetics during induction of MCM and AS cells
in order to differentiate between these alternative
modes.
Since constitutive elevation of CaM levels (as occurs
in CM cells) results in a shortening of the cell cycle,
we were interested in determining if this was accom-
panied by changes in the levels of mRNAs normally
regulated in a cell cycle-dependent manner. Cytoplas-
mic RNA was isolated from mitotically synchronized
cells (24) at various times after mitosis, and the levels
of several different mRNAs were quantitated by
hybridization (16) to radiolabeled cDNA probes.
Two genes, glyceraldehyde phosphate dehydroge-
nase and histone H4, were examined since the first
has been reported not to change over a variety of
growth conditions, and the second provides an inter-
nal control for normal progression through the cell
cycle, since the mRNA maximally accumulates in the
S phase (25). No significant change in cell cycle-
dependent levels of either mRNA was observed
between BPV and CM cells for either glyceraldehyde
phosphate GAPDH or histone-H4 mRNAs. Thus, ele-
vated CaM in CM cells does not cause general changes
in mRNA levels during the cell cycle.
However, several mRNAs did demonstrate changes
in levels during the cell cycle in CM versus BPV cells.
,-actin mRNA was elevated 30% in CM relative to
BPV cells. Previous studies have shown that actin
mRNA levels are elevated to more rapidly proliferat-
ing cells. In contrast, P-tubulin mRNA is decreased
nearly 2-fold in CM cells. Measurements of mRNA
half-life in BPV and CM cells show that P-tubulin
mRNA has a 30% shorter half-life in CM cells, while
the half-lives for ,-actin and CaM are unchanged.
Previous studies both in vivo and in vitro have
demonstrated that CaM can cause Ca2+-dependent
depolymerization of microtubules and that increased
levels of tubulin dimer cause a decrease in P-tubulin
mRNA due to a decrease in mRNA stability. The
observation that P-tubulin mRNA is decreased due to
a decreased stability in CM cells is consistent with
these studies.
Both vimentin and c-myc mRNAs have been
reported to be regulated in a cell cycle-dependent
manner. The vimentin mRNA is normally expressed
in G1 (28) and is increased 50% in CM cells relative to
BPV cells. These data might be expected since the G1
period in CM cells is more rapid than in BPV cells. On
the other hand, c-myc mRNA was elevated 2-fold in
CM cells, compared to BPV cells at all phases of the
cell cycle. In addition c-myc mRNA was found to
increase 2- to 3-fold as cells from either clone
progressed from M to G1. Previous studies examining
c-myc mRNA levels have not observed this change, as
these studies did not use mitotic selection as a syn-
chronization method and thus were not able to
examine changes in mRNA levels prior to mid-G1.
Calmodulin has also been shown to be important in
the reentry of quiescent cells into the proliferative
cycle in response to mitogen. Preliminary studies
indicate that CM cells reenter the cell cycle more rap-
idly than do BPV cells. Since the metallothionein pro-
moters are inducible under any growth conditions, we
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are currently examining the effect of induced
increases (in MCM cells) or decreases (in AS cells) on
the kinetics of cell cycle reentry, and the effects of
changes in CaM levels on mRNA levels of genes
known to be induced when quiescent cultures are
stimulated to reenter the cell cycle (e.g., c-myc, c-fos,
vimentin, actin).
Summary
Calmodulin levels in cells have been increased or
decreased bythe use of BPV-based expression vectors.
Our results have demonstrated a direct relationship
between intracellular CaM concentration and cell
proliferation. The constitutive elevation of CaM, as
occurs in CM cells, exerts effects primarily on the
length ofthe G1 period, while transient increase (as in
MCM cells) or decrease (as in AS cells) of CaM levels
may affect proliferation by acting at multiple points
within the cell cycle. The cell lines, which we now
have, allow us to begin analysis of the intracellular
targets through which CaM regulates cell growth.
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